Skip to main content
. 2020 Jun 24;58(7):e00135-20. doi: 10.1128/JCM.00135-20

FIG 2.

FIG 2

Molecular tests for viral pathogens were clinically ordered for only 93/259 (35.9%) BAL specimens submitted for bacterial culture and included primarily multiplexed respiratory panel tests (A). At least one viral target was detected by the PN panel in 46/259 (17.7%) BAL specimens, either alone or in addition to bacterial targets (B). Only 11/46 (23.9%) specimens with a positive viral detection by the PN panel had a clinician-ordered molecular test for viral pathogens.